Korro Bio's market cap is currently $361.83M. The company's EPS TTM is $-2.74; its P/E ratio is ―; Korro Bio is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is $-2.59. See an overview of income statement, balance sheet, and cash flow financials.
